Kontrol BioCloud Delivers Multiple Successful Real-Time COVID-19 Detections -BioCloud Positive Detection Confirmed by Third-Party Laboratory Testing and Generates Significant Data and Analytics- TORONTO, ON November 15
th, 2021 -
Kontrol Technologies Corp. (
NEO:KNR) (
OTCQB:KNRLF) (
FSE:1K8) ("
Kontrol" or the "
Company") a leader in smart buildings and cities through IoT, Cloud and SaaS technology, today announced that the Kontrol BioCloud (or "BioCloud") technology delivered repeated, real-time detections of COVID-19 from four individuals.
The successful detection was completed as part of Kontrol's internal data, analytics, and reporting, as supported by PCR testing and independent laboratory confirmation of positive detection results.
"Completing multiple successful positive detections represents another significant milestone achieved for BioCloud,” said Paul Ghezzi, CEO of Kontrol. “In addition, we were able to collect a significant amount of real-time data that will provide additional value to our partners, customers and other applicable relevant organizations. The in-field validation provides critical information on the operation of BioCloud in the presence of the SARS-CoV-2 virus and further advances BioCloud as a leading ambient air monitoring technology."
The data collocated is based on a number of metrics which are divided into four primary sections in the results compiled by the Company. See link to report at https://kontrolbiocloud.com/positivedetection - Determination of BioCloud detection response in a defined area
- Determination of SARS-CoV-2 viral collection efficiency from the BioCloud analyzer target system with independent validation from a laboratory PCR test
- Examine and monitor SARS-CoV-2 virus concentration distribution and variations in a defined area during various uses of that area
- Examine participant viral shedding response over a period of time
"BioCloud was designed as an early detection system for viruses and pathogens by continuously monitoring and sampling the ambient air in rooms where individuals gather," said Gary Saunders, President of Kontrol BioCloud. "The results achieved through real-time detection of the SARS-CoV-2 virus is further validation of the value of our technology, and the important data collected in real-time will be shared with researchers and government agencies.”
Further updates on BioCloud will be provided on the Q3 Conference Call. Kontrol will host a conference call on Monday, November 15th, 2021, at 4:30 PM EST to discuss Kontrol’s third quarter 2021 financial results.